At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 503 enrolled
Drug / intervention
A-101 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Phase 3 Randomized, Double-Blind, Vehicle-Controlled, Parallel Group Study of A-101 Topical Solution Applied Twice a Week in Subjects With Common Warts
In Brief
A Phase 3 clinical trial evaluating A-101 and vehicle for Common Wart. Completed, enrolled 503 participants across 24 sites.
Detailed Summary
A Phase 3 Study of A-101 Topical Solution Applied Twice a Week in Subjects with Common Warts
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCommon Wart
CountriesUnited States
Collaborators--
Timeline
Phase 3CompletedFinished
20192020202120222023202420252026
Enrollment StartSep 2018
First PostedSep 2018
Primary CompletionJun 2019
Study CompletionSep 2019
TodayJul 2026
First PostedSep 27, 2018
Enrollment StartSep 17, 2018
Primary CompletionJun 20, 2019
Study CompletionSep 6, 2019
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 7.8 years ago
Interventions
A-101drug
hydrogen peroxide topical solution 45%
vehicleother
vehicle as a topical solution